Folacci M, Chalmers S, Davis F
Methods Mol Biol. 2024; 2861:195-212.
PMID: 39395107
DOI: 10.1007/978-1-0716-4164-4_15.
Kumari N, Pullaguri N, Rath S, Bajaj A, Sahu V, Ealla K
Cancer Drug Resist. 2024; 7:11.
PMID: 38510751
PMC: 10951838.
DOI: 10.20517/cdr.2023.145.
Yi T, Wagner G
Proc Natl Acad Sci U S A. 2024; 121(6):e2317141121.
PMID: 38294933
PMC: 10861905.
DOI: 10.1073/pnas.2317141121.
Jeong J, Lee J, Talaia G, Kim W, Song J, Hong J
Cell Mol Life Sci. 2024; 81(1):29.
PMID: 38212474
PMC: 10784359.
DOI: 10.1007/s00018-023-05044-8.
Park K, Kim J, Kim S, Kim S, Lim J, Kim M
BMC Med. 2023; 21(1):38.
PMID: 36726166
PMC: 9893610.
DOI: 10.1186/s12916-023-02727-8.
Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah.
Zhang Z, Bassale S, Jindal S, Fraser A, Guinto E, Anderson W
JAMA Netw Open. 2022; 5(10):e2236763.
PMID: 36239933
PMC: 9568799.
DOI: 10.1001/jamanetworkopen.2022.36763.
Alterations in the Ca toolkit in oesophageal adenocarcinoma.
Cutliffe A, McKenna S, Chandrashekar D, Ng A, Devonshire G, Fitzgerald R
Explor Target Antitumor Ther. 2022; 2(6):543-575.
PMID: 36046118
PMC: 9400700.
DOI: 10.37349/etat.2021.00063.
Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma.
Lim J, Park K, Choi K, Kim C, Lee J, Weicker R
Int J Mol Sci. 2022; 23(14).
PMID: 35887321
PMC: 9322808.
DOI: 10.3390/ijms23147971.
Calcium Signalling in Breast Cancer Associated Bone Pain.
Bortolin A, Neto E, Lamghari M
Int J Mol Sci. 2022; 23(3).
PMID: 35163823
PMC: 8836937.
DOI: 10.3390/ijms23031902.
The butyrophilin 1a1 knockout mouse revisited: Ablation of leads to concurrent cell death and renewal in the mammary epithelium during lactation.
Jeong J, Kadegowda A, Meyer T, Jenkins L, Dinan J, Wysolmerski J
FASEB Bioadv. 2021; 3(12):971-997.
PMID: 34938960
PMC: 8664049.
DOI: 10.1096/fba.2021-00059.
Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer.
Lorona N, Cook L, Tang M, Hill D, Wiggins C, Li C
Cancer Causes Control. 2021; 32(12):1375-1384.
PMID: 34347212
PMC: 8541909.
DOI: 10.1007/s10552-021-01485-3.
Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression.
Mesquita G, Prevarskaya N, Schwab A, Lehenkyi V
Cells. 2021; 10(5).
PMID: 33925979
PMC: 8145744.
DOI: 10.3390/cells10051021.
Epigallocatechin 3-gallate inhibits the plasma membrane Ca-ATPase: effects on calcium homeostasis.
Rinaldi D, Ontiveros M, Saffioti N, Vigil M, Mangialavori I, Rossi R
Heliyon. 2021; 7(2):e06337.
PMID: 33681501
PMC: 7930289.
DOI: 10.1016/j.heliyon.2021.e06337.
Calcium signaling: breast cancer's approach to manipulation of cellular circuitry.
Pratt S, Hernandez-Ochoa E, Martin S
Biophys Rev. 2021; 12(6):1343-1359.
PMID: 33569087
PMC: 7755621.
DOI: 10.1007/s12551-020-00771-9.
The histone deacetylase inhibitor PCI-24781 impairs calcium influx and inhibits proliferation and metastasis in breast cancer.
Yang T, Wang P, Yin X, Zhang J, Huo M, Gao J
Theranostics. 2021; 11(5):2058-2076.
PMID: 33500709
PMC: 7797697.
DOI: 10.7150/thno.48314.
Transcriptional and epigenetic landscape of Ca-signaling genes in hepatocellular carcinoma.
Hernandez-Oliveras A, Izquierdo-Torres E, Hernandez-Martinez G, Zarain-Herzberg A, Santiago-Garcia J
J Cell Commun Signal. 2021; 15(3):433-445.
PMID: 33398721
PMC: 8222487.
DOI: 10.1007/s12079-020-00597-w.
Calcium Metabolism and Breast Cancer: Echoes of Lactation?.
Grinman D, Athonvarungkul D, Wysolmerski J, Jeong J
Curr Opin Endocr Metab Res. 2020; 15:63-70.
PMID: 33299957
PMC: 7720883.
DOI: 10.1016/j.coemr.2020.11.006.
Breast Cancer and Microcalcifications: An Osteoimmunological Disorder?.
Clemenceau A, Michou L, Diorio C, Durocher F
Int J Mol Sci. 2020; 21(22).
PMID: 33203195
PMC: 7696282.
DOI: 10.3390/ijms21228613.
Targeting the Calcium Signalling Machinery in Cancer.
Bruce J, James A
Cancers (Basel). 2020; 12(9).
PMID: 32825277
PMC: 7565467.
DOI: 10.3390/cancers12092351.
Ca as a therapeutic target in cancer.
Gross S, Mallu P, Joshi H, Schultz B, Go C, Soboloff J
Adv Cancer Res. 2020; 148:233-317.
PMID: 32723565
PMC: 7412871.
DOI: 10.1016/bs.acr.2020.05.003.